Expression profile of microrna-145 in urothelial bladder cancer

International Braz J Urol

Volumn 39, Issue 1, 2013, Pages 95-101

  Dip Júnior, Nelson Gaspar ^a   Reis, Sabrina T ^a   Srougi, Miguel ^a   Dall'Oglio, Marcos F ^a   Leite, Katia R M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biological Markers; Diagnostic Technique; Human Supplementary Concept ; MicroRNAs; MIRN145 microRNA; Urinary Bladder; Urological

Indexed keywords

CARCINOGEN; MICRORNA; MIRN145 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLADDER TUMOR; CANCER GRADING; EVALUATION STUDY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOGENS; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84878464555     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-5538.IBJU.2013.01.12     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90. Epub 2011 Feb 4. Erratum in: CA Cancer J Clin. 2011; 61: 134.
2. Jebar AH, Hurst CD, Tomlinson DC, Johnston C, Taylor CF, Knowles MA: FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene. 2005; 24: 5218-25.
3. McConkey DJ, Lee S, Choi W, Tran M, Majewski T, LeeS, et al.: Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression. Urol Oncol. 2010; 28: 429-40.
4. Borden LS Jr, Clark PE, Hall MC: Bladder cancer. Curr Opin Oncol. 2005; 17: 275-80.
5. van Rhijn BW, van der Kwast TH, Vis AN, Kirkels WJ, Boevé ER, Jöbsis AC, et al.: FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma. Cancer Res. 2004 15; 64: 1911-4.
6. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C: Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol. 2010; 28: 401-8.
7. Pandith AA, Shah ZA, Siddiqi MA: Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer. Urol Oncol. 2010; 3. [Epub ahead of print]
8. Bakkar AA, Wallerand H, Radvanyi F, Lahaye JB, Pissard S, Lecerf L, et al.: FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Res. 2003; 63: 8108-12.
9. Wu XR: Biology of urothelial tumorigenesis: insights from genetically engineered mice. Cancer Metastasis Rev. 2009; 28: 281-90.
10. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, et al.: J Biol Chem. 1996 21; 271: 15292-7.
11. Lewis BP Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005 14; 120: 15-20.
12. Ambros V: MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003 13; 113: 673-6. Review. Erratum in: Cell. 2003; 114: 269.
13. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97.
14. Croce CM, Calin GA: miRNAs, cancer, and stem cell division. Cell. 2005; 122: 6-7.
15. Blenkiron C, Miska EA: miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet. 2007; 16 Spec No 1: R106-13.
16. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al.: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102: 13944- 9. Erratum in: Proc Natl Acad Sci U S A. 2006; 103: 2464.
17. Lin T, Dong W, Huang J, Pan Q, Fan X, Zhang C, et al.: MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol. 2009; 181: 1372-80.
18. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al.: RAS is regulated by the let-7 microRNA family. Cell. 2005; 120: 635-47.
19. Catto JW, Miah S, Owen HC, Bryant H, Myers K, Dudziec E, et al.: Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res. 2009; 69: 8472-81.
20. Ozen M, Creighton CJ, Ozdemir M, Ittmann M: Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008; 27: 1788-93.
21. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S: Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009; 23: 806-12.
22. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, et al.: p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A. 2009; 106: 3207-12.
23. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003; 1: 882-91.
24. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, Baserga R: Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem. 2007 9; 282: 32582-90.
25. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, et al.: Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer. 2009; 125: 345-52.
26. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, et al.: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer. 2010; 102: 883-91.
27. Sachdeva M, Mo YY: miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res. 2010; 2: 170-80.
28. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K: Modulation of microRNA processing by p53. Nature. 2009; 460: 529-33.
29. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, et al.: miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 2010; 17: 246-54.
30. Vignjevic D, Kojima S, Aratyn Y, Danciu O, Svitkina T, Borisy GG: Role of fascin in filopodial protrusion. J Cell Biol. 2006; 174: 863-75.